跳转至内容
Merck
CN

ABN905

Anti-α-Synuclein (SNCA) Antibody

rabbit polyclonal

别名:

Non-A beta component of AD amyloid, Non-A4 component of amyloid precursor, NACP

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Clone:
polyclonal
Species reactivity:
human, mouse, rat
Application:
IHC, WB
Citations:
-
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

Anti-alpha-Synuclein, from rabbit, purified by affinity chromatography

biological source

rabbit

antibody form

affinity isolated antibody

antibody product type

primary antibodies

clone

polyclonal

purified by

affinity chromatography

species reactivity

human, mouse, rat

packaging

antibody small pack of 25 μg

technique(s)

immunohistochemistry: suitable (paraffin), western blot: suitable

NCBI accession no.

UniProt accession no.

target post-translational modification

unmodified

Gene Information

human ... SNCA(6622)

General description

Alpha-synuclein (UniProt: P37840; also known as Non-A beta component of AD amyloid, Non-A4 component of amyloid precursor, NACP) is encoded by the SNCA (also known as NACP, PARK1) gene (Gene ID: 6622) in human. Alpha-synuclein is abundantly expressed in the brain and is found in a classic amyloid fibril form within the intra-neuronal Lewy body deposits of Parkinson′s disease brains. The physiological function of synucleins is not well understood, but appears to involve membrane interactions, and in particular reversible binding to synaptic vesicle membranes. It may also be involved in the regulation of dopamine release and transport. It is also reported to reduce neuronal responsiveness to various apoptotic stimuli, leading to a decreased caspase-3 activation. Genetic alterations of SNCA gene is reported to result in aberrant polymerization into fibrils, which is associated with several neurodegenerative diseases (synucleinopathies). Mutations in SNCA gene are also known to Parkinson′s disease characterized by bradykinesia, resting tremor, muscular rigidity and postural instability. The pathology of Parkinson s disease involves progressive loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies in surviving neurons in various areas of the brain.
~17 kDa observed; 14.46 kDa calculated. Uncharacterized bands may be observed in some lysate(s).

Immunogen

KLH-conjugated linear peptide corresponding to 21 amino acids from the C-terminal region of human Alpha-Synuclein.

Application

Anti-alpha-Synuclein, Cat. No. ABN905, is a rabbit polyclonal antibodt that detects alpha synuclein and has been tested for use in Immunohistochemistry (Paraffin) and Western Blotting.
Western Blotting Analysis: A 1:1,000-2,000 dilution from a representative lot detected alpha-Synuclein in human and rat brain tissue lysate.

Immunohistochemistry (Paraffin) Analysis: A 1:2,000-3,000 dilution from a representative lot detected alpha-Synuclein in human cerebral cortex and rat cerebellum tissue sections.

Biochem/physiol Actions

This rabbit polyclonal antibody detects alpha synuclein in human, mouse, and rat. It targets an epitope with in 21 amino acids from the C-terminal region.

Analysis Note

Evaluated by Western Blotting in mouse brain tissue lysate.

Western Blotting Analysis: A 1:500 dilution of this antibody detected alpha-Synuclein in mouse brain tissue lysate.

Other Notes

Concentration: Please refer to lot specific datasheet.


Still not finding the right product?

Explore all of our products under

或者

试用我们的 产品选型工具 工具缩小选择范围


法规信息

新产品

此项目有



分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



全球贸易项目编号

货号GTIN
ABN905-25UG04054839531842
ABN905-100UG04054839531835